Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,548 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted Marrow Irradiation Intensification of Reduced-Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation.
Ali N, Sharma AA, de Rezende ACP, Otegbeye F, Latif BM, Kerbauy MN, Cooper BW, Sanchez G, Metheny L, Bal SK, Sakuraba R, Tomlinson BK, Boughan KM, Kerbauy L, Malek E, Ribeiro AF, Gallogly M, Mansur D, Pereira G, Weltman E, Sekaly RP, de Lima M, Caimi PF, Hamerschlak N. Ali N, et al. Transplant Cell Ther. 2022 Jul;28(7):370.e1-370.e10. doi: 10.1016/j.jtct.2022.04.001. Epub 2022 Apr 11. Transplant Cell Ther. 2022. PMID: 35421620 Free article. Clinical Trial.
Immune Signatures Associated With Clonal Isotype Switch After Autologous Stem Cell Transplantation for Multiple Myeloma.
Ye R, Kundrapu S, Gerson SL, Driscoll JJ, Beck R, Ali N, Landgren O, VanHeeckeren W, Luo G, Kroger N, Caimi P, De Lima M, Malek E. Ye R, et al. Among authors: ali n. Clin Lymphoma Myeloma Leuk. 2019 May;19(5):e213-e220. doi: 10.1016/j.clml.2018.12.022. Epub 2019 Jan 3. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30878316 Free PMC article.
Conditioning regimen intensity and low-dose azacitidine maintenance after allogeneic hematopoietic cell transplantation for acute myeloid leukemia.
Ali N, Tomlinson B, Metheny L, Goldstein SC, Fu P, Cao S, Caimi P, Patel RD, Varela JC, Andrade L, Balls JW, Baer L, Smith M, Smith T, Nelson M, de Lima M, Mori S. Ali N, et al. Leuk Lymphoma. 2020 Dec;61(12):2839-2849. doi: 10.1080/10428194.2020.1789630. Epub 2020 Jul 10. Leuk Lymphoma. 2020. PMID: 32650686
Physical Activity and Sleep Measures Using a Fitness Tracking Device during Hematopoietic Cell Transplantation: A Pilot Study.
Jurdi NE, Nock N, Fu P, Cao S, Cotton JM, Ali N, Ravi G, Pinto R, Galloway E, Kolke S, Cooper B, Tomlinson B, Malek E, Lance C, Kolk MJ, Ferrari N, Lee R, de Lima M, Caimi PF, Metheny L. Jurdi NE, et al. Among authors: ali n. Transplant Cell Ther. 2021 Jun;27(6):502.e1-502.e6. doi: 10.1016/j.jtct.2021.02.015. Epub 2021 Feb 19. Transplant Cell Ther. 2021. PMID: 33827757 Free article.
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis.
Vincelette ND, Yu X, Kuykendall AT, Moon J, Su S, Cheng CH, Sammut R, Razabdouski TN, Nguyen HV, Eksioglu EA, Chan O, Al Ali N, Patel PC, Lee DH, Nakanishi S, Ferreira RB, Hyjek E, Mo Q, Cory S, Lawrence HR, Zhang L, Murphy DJ, Komrokji RS, Lee D, Kaufmann SH, Cleveland JL, Yun S. Vincelette ND, et al. Among authors: al ali n. Blood Cancer Discov. 2024 May 7. doi: 10.1158/2643-3230.BCD-23-0210. Online ahead of print. Blood Cancer Discov. 2024. PMID: 38713018
3,548 results